20 April 2021, the PharmaZell Group one on Europe’s leading manufacturer of active ingredients, is pleased to announce its production site FarmaBios SpA (in Gropello/Italy) has received validation from the European Commission (“EC”), and European Food Safety Authority (“EFSA”) for the dossier on synthetic CBD as a Novel Food.
PZ-Group-CBD-Dossier-EU-validation-final-May-2021